Babesiosis incidence in u.s. 10x higher than cdc estimates, according to insurance claims study commissioned by 60 degrees pharmaceuticals

Insurance claims show u.s. babesiosis incidence may be 10x cdc estimates; 60 degrees links chronic fatigue and plans 2026 nda for tafenoquine treatment.
SXTP Ratings Summary
SXTP Quant Ranking